背景介紹/context：

For research agnostic to donor profile, these cells are sourced from young (<30 y.o.), healthy donors (male or female) at early passage (P2; PDL 6.5 - 8.0) and selected for their rapid, consistent expansion and differentiation capabilities.

Highlights: 

Cells are grown in antibiotic-free mediumVerified to express CD44, CD73, CD90, CD105, CD166Confirmed negative for CD14, CD34, CD45, and HLADRAll lots have confirmed ability to differentiate through P6.

Extem mesenchymal stem cells are isolated from human bone marrow using a proprietary process that optimizes for lot size and minimal cellular disruption during extraction. Extem cells exceed industry-standard performance metrics for growth consistency and differentiation ability.

對(duì)于供體資料未知的研究，這些細(xì)胞來(lái)源于年輕(30歲)、健康的早期供體(男性或女性)(P2;PDL 6.5 - 8.0)，并選擇其快速、持續(xù)的擴(kuò)張和差異化能力。

重點(diǎn):

在無(wú)抗生素的培養(yǎng)基中培養(yǎng)的細(xì)胞經(jīng)驗(yàn)證表達(dá)CD44、CD73、CD90、CD105、cd166證實(shí)CD14、CD34、CD45為陰性，HLADRAll lot經(jīng)P6證實(shí)具有分化能力。

間充質(zhì)干細(xì)胞通過(guò)專(zhuān)利工藝從人類(lèi)骨髓中分離出來(lái)，該工藝優(yōu)化了lot大小，在提取過(guò)程中細(xì)胞破壞最小。在生長(zhǎng)一致性和分化能力方面，間充質(zhì)干細(xì)胞超過(guò)了行業(yè)標(biāo)準(zhǔn)的性能指標(biāo)。

動(dòng)物種別/Organism  人

組織來(lái)源 Tissue and Cell Type 骨髓

形態(tài)/Morphology 貼壁生長(zhǎng) 

注意事項(xiàng)：此產(chǎn)品僅供科研使用